awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38698960-012F150B-3C35-4020-98D2-04ED24228C5B
Q38698960-012F150B-3C35-4020-98D2-04ED24228C5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38698960-012F150B-3C35-4020-98D2-04ED24228C5B
Review of phase III trial data on IL-23 inhibitors tildrakizumab and guselkumab for psoriasis.
P2860
Q38698960-012F150B-3C35-4020-98D2-04ED24228C5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38698960-012F150B-3C35-4020-98D2-04ED24228C5B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
818d227348a4cf5ba989c6c5e3109b1fc23c1fd6
P2860
Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases